Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 3.5S - 9 mm: medical device reports filed with FDA

5,023 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

5,023
device reports naming the brand
0% of all MAUDE reports · about 709 a year
687
reports, 12 months to August 2026
668 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

5,023 medical device reports received by FDA name the brand "OsseoSpeed TX 3.5S - 9 mm" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

687 reports arrived in the 12 months to August 2026, close to the 668 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (37.1%), failure to osseointegrate (33.1%) and loss of osseointegration (26.7%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

052103Sep 2021: 33Oct 2021: 43Nov 2021: 58Dec 2021: 492022Jan 2022: 81Feb 2022: 59Mar 2022: 84Apr 2022: 103May 2022: 45Jun 2022: 36Jul 2022: 41Aug 2022: 69Sep 2022: 37Oct 2022: 52Nov 2022: 56Dec 2022: 632023Jan 2023: 61Feb 2023: 51Mar 2023: 62Apr 2023: 49May 2023: 49Jun 2023: 62Jul 2023: 44Aug 2023: 51Sep 2023: 73Oct 2023: 59Nov 2023: 57Dec 2023: 332024Jan 2024: 51Feb 2024: 76Mar 2024: 64Apr 2024: 73May 2024: 58Jun 2024: 75Jul 2024: 72Aug 2024: 102Sep 2024: 62Oct 2024: 69Nov 2024: 53Dec 2024: 422025Jan 2025: 45Feb 2025: 40Mar 2025: 93Apr 2025: 24May 2025: 43Jun 2025: 55Jul 2025: 77Aug 2025: 65Sep 2025: 72Oct 2025: 45Nov 2025: 45Dec 2025: 352026Jan 2026: 72Feb 2026: 50Mar 2026: 52Apr 2026: 84May 2026: 41Jun 2026: 43Jul 2026: 89Aug 2026: 59

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

07891,5782019: 14220192021: 1,57820212022: 72620222023: 65120232024: 79720242025: 63920252026: 4902026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,023
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%5,023
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem1,86237.1%7.7%
Failure to osseointegrate1,66333.1%62.8%
Loss of osseointegration1,34026.7%22.4%
Fracturea broken bone1753.5%1.6%
Crackthe device cracked200.4%0%
Loosening of implant not related to bone-ingrowth190.4%0.1%
Damaged thread70.1%0%
Off-label use60.1%0%
Insufficient device problem information30.1%0.2%
Device dislodged or dislocated20%0%
Malposition of device20%0.1%
Migration or expulsion of device20%0%
Difficult to insertthe device was hard to insert10%0.4%
Overfill10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant5,00699.7%
Inflammationinflammation64312.8%
Osteolysis2755.5%
Pocket erosion2414.8%
Implant pain90.2%
Inadequate osseointegration60.1%
Painpain, site not specified30.1%
Abscessa collection of pus10%
Deformity/ disfigurement10%
Fistula10%
Laceration(s)10%
Sinus perforation10%
Swelling/ edema10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 3.5S - 9 mmProduct code DZEAll MAUDE reports
Reports5,0233,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 3.5S - 9 mm reports

How many FDA reports name OsseoSpeed TX 3.5S - 9 mm?

5,023 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 687 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (37.1%), failure to osseointegrate (33.1%), loss of osseointegration (26.7%), fracture (3.5%) and crack (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 3.5S - 9 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.